|
|
| | HBV/HDV-IN-3 Basic information |
| Product Name: | HBV/HDV-IN-3 | | Synonyms: | HBV/HDV-IN-3;Benzamide, 4-[(6R)-7-[4-bromo-3-(trifluoromethyl)benzoyl]-5,6,7,8-tetrahydro-6-methyl-2-[[(1S)-1-methyl-2-propen-1-yl]amino]-4-oxopyrido[3,4-d]pyrimidin-3(4H)-yl]-N-methyl- | | CAS: | 2883679-03-4 | | MF: | C28H27BrF3N5O3 | | MW: | 618.45 | | EINECS: | | | Product Categories: | | | Mol File: | 2883679-03-4.mol |  |
| | HBV/HDV-IN-3 Chemical Properties |
| density | 1.47±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 15.12±0.46(predicted) |
| | HBV/HDV-IN-3 Usage And Synthesis |
| Uses | HBV/HDV-IN-3 (Compd 1) is a dual HBV and HDV inhibitor, with an EC50 of <50 nM against HBV[1]. | | References | [1] Sandrine Vendeville, et al. Bicyclic compounds. Patent. WO2024073559A1. |
| | HBV/HDV-IN-3 Preparation Products And Raw materials |
|